Thomas Lategan
Consejero General en BRIGHT MINDS BIOSCIENCES INC. .
Cargos activos de Thomas Lategan
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Consejero General | 14/06/2021 | - |
Historial de carrera de Thomas Lategan
Antiguos cargos conocidos de Thomas Lategan.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Consejero General | 01/09/2008 | 01/11/2015 |
| PANACOS PHARMACEUTICALS, INC. | Consejero General | 01/02/2007 | 01/09/2008 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Consejero General | 01/02/2000 | 01/02/2007 |
| THE MEDICINES COMPANY | Consejero General | 01/03/1997 | 01/02/2000 |
| Roche Corp. | Corporate Officer/Principal | - | - |
Formación de Thomas Lategan.
| University of Oxford | Doctorate Degree |
| University of Aberdeen | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Reino Unido | 3 |
| Canadá | 2 |
Operativa
| General Counsel | 5 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Commercial Services |
| Roche Corp. |
- Bolsa de valores
- Insiders
- Thomas Lategan
- Experiencia
